高胆固醇血症和缺血性心脏病之间的双向因果关系:孟德尔的随机化研究
Ying Jiang1, Wenpeng Yu1, Jianliang Zhou2
1Department of Cardiovascular Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
Frontiers in cardiovascular medicine
|December 25, 2023
概括
这项研究使用遗传数据表明,高胆固醇 (高胆固醇血症) 和缺血性心脏病 (IHD) 有双向因果关系. 确定了像APOE这样的共享基因,这表明了这两种疾病的新治疗点.
科学领域:
- 心血管遗传学 心血管遗传学
- 代谢障碍 代谢障碍 代谢障碍
- 流行病学 流行病学
背景情况:
- 缺血性心脏病 (IHD) 是一个主要的全球健康问题.
- 高胆固醇血清症,以高胆固醇水平为特征,与IHD有关.
- 高胆固醇血症和IHD之间的确切因果关系需要进一步阐明.
研究的目的:
- 通过使用遗传证据,研究高胆固醇和IHD之间的双向因果关系.
- 识别导致两种疾病的共同遗传因素.
- 在基因洞察的基础上探索潜在的治疗点.
主要方法:
- 进行了两样本的孟德尔随机化 (MR) 分析.
- 使用与高胆固醇血症和IHD相关的遗传变异.
- 使用多种统计方法 (MR-Egger,IVW,加权中位数) 和灵敏度分析.
- 进行了遗传共定位分析,以确定共享的基因.
主要成果:
- 证实了高胆固醇和IHD之间存在显著的双向因果关系.
- 增加IHD的几率与高胆固醇血症相关 (OR=2.27).
- 增加高胆固醇血的几率与IHD相关 (OR=1.80).
- 四个基因 (CELSR2,PCSK9,LPA,APOE) 被确定为同局部,可能与这两种疾病有关.
结论:
- 门德尔的随机化为高胆固醇血症和IHD之间的因果关系提供了遗传证据.
- 这些发现支持双向关系,IHD可能会影响高胆固醇血症.
- 同局部化分析表明共享的遗传因果变异,为新的治疗策略提供了目标.
相关概念视频
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Cholesterol: Significance and Regulation
551
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
551
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
519
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
519


